UBS Group’s Harte-Hanks HHS Stock Holding History
Bought
Maintained
Sold
Other funds holding HHS
JC
CL
UBS Group's HHS Position: Q3 2026 in Review
UBS Group increased its Harte-Hanks (HHS) stake by 104% in Q3 2026, buying an estimated $539 and bringing the position to 310 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #10264.
UBS Group first reported a position in HHS in Q2 2013 and has held it in 39 quarters since. The position peaked at $193K in Q2 2025. 31 funds tracked by Wall St. Rank hold HHS as of Q3 2026.
- UBS Group held 310 shares of Harte-Hanks worth $1.41K as of Q3 2026.
- UBS Group bought 158 Harte-Hanks shares in Q3 2026, an estimated $539.
- Harte-Hanks made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #10264 holding.
- UBS Group first reported a position in Harte-Hanks in Q2 2013 and has held it in 39 quarters since.
- UBS Group's Harte-Hanks position peaked at $193K in Q2 2025.
- 31 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.